Hence, in the metastatic NSCLC cell line, TGF-β shifts the PAI-1/uPA expression ratio decisively towards uPA and thus enhances two cell migration promoting pathways: cytoskeleton remodeling and plasmin activity. This evidence concerns the gene PLAU and non-small cell lung carcinoma.